ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
How to realistically turn a $7,000 ASX share portfolio into $75,000 by 2030
Blue Chip Shares
2 of the highest-quality blue chip ASX 200 stocks money can buy
Broker Notes
Up 45% in 2024! Can ResMed shares keep rising?
Broker Notes
Top brokers name 3 ASX shares to buy next week
Dividend Investing
Want the latest ResMed dividend? Here's what you need to do
Best Shares
Top ASX shares to buy in November 2024
Healthcare Shares
Why this fundie is backing ResMed shares in FY25
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why DroneShield, Newmont, ResMed, and Vulcan Energy shares are storming higher
Broker Notes
Leading brokers name 3 ASX shares to buy today
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why Aussie Broadband, HMC Capital, ResMed, and WiseTech shares are storming higher
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.